NCT07568951 Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease
| NCT ID | NCT07568951 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2029-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2023-08-01 with a primary completion date of 2029-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Both aging and Parkinson's disease (PD) negatively affect postural control and increase the risk of falls, with frontal plane balance being particularly challenging for these populations. While previous studies have mainly focused on sagittal plane balance, the contribution of hip abductor muscles remains unclear, especially regarding their force production and control abilities. Therefore, this study aims to investigate hip abductor muscle force production and force control, and to examine whether these factors are associated with postural control, gait, and balance performance in individuals across different ages and those with PD.
Eligibility Criteria
Healthy people Inclusion Criteria: * 20 to 39 years (young), 40 to 59 years (young), and 60-85 years (old) * generally in good health * able to walk 10 m independently * able to follow all instructions Exclusion Criteria: * neurologic, psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study * any pain over the lower extremities * uncontrolled cardiovascular diseases * unable to provide informed consent. PD Inclusion Criteria: * clinical diagnosis of idiopathic PD * Hoehn and Yahr stages 1 to 3 * stable anti-PD medications * able to walk 10 m independently * able to follow all instructions Exclusion Criteria: * psychiatric, immune, integumentary, and musculoskeletal diseases or disorders which might influence this study * neurological conditions other than PD * any pain over the lower extremities * uncontrolled cardiovascular diseases * unable to provide informed consent.
Contact & Investigator
Chu-Ling Yen
PRINCIPAL INVESTIGATOR
Chang Gung University
Frequently Asked Questions
Who can join the NCT07568951 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 85 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07568951 currently recruiting?
Yes, NCT07568951 is actively recruiting participants. Contact the research team at clyen@mail.cgu.edu.tw for enrollment information.
Where is the NCT07568951 trial being conducted?
This trial is being conducted at Taoyuan, Taiwan, Taoyuan, Taiwan.
Who is sponsoring the NCT07568951 clinical trial?
NCT07568951 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Chu-Ling Yen at Chang Gung University. The trial plans to enroll 210 participants.